A recent Politico article noted that Pfizer and its partner BioNTech are seeking full approval from the FDA for their Covid-19 vaccine for people 16 and older. The two-dose protection against coronavirus received emergency use authorization earlier this year, which allowed it to be one of three vaccines used in the pandemic battle. Full approval means the companies would be able to market the shot directly to consumers, and make it easier for schools, employers, and the military to require vaccination against Covid-19.
Pfizer Eyes Full FDA Approval for Covid-19 Vaccine
Pfizer and partner BioNTech are the first vaccine manufacturers to seek full approval in the U.S.
May 10, 2021
Sustainable Healthcare Packaging Solutions That Work
Industry leaders share proven strategies for reducing packaging emissions by up to 70% while meeting safety and regulatory requirements.
Read More
List: Digitalization Companies From PACK EXPO
Looking for CPG-focused digital transformation solutions? Download our editor-curated list from PACK EXPO featuring top companies offering warehouse management, ERP, digital twin, and MES software with supply chain visibility and analytics capabilities—all tailored specifically for CPG operations.
Download Now
Downloads
